Medivir has today submitted an NDA to the US FDA for Lipsovir, a topical product for prevention and treatment of cold sores.
Lipsovir is a patented combination of hydrocortisone (an anti-inflammatory agent) and aciclovir (an antiviral agent) in a proprietary cream base developed by Medivir.
The details can be read here.
No comments:
Post a Comment